🇺🇸 FDA
Pipeline program

GM-CT-01

DAVFU006

Phase 2 small_molecule terminated

Quick answer

GM-CT-01 for Colorectal Cancer is a Phase 2 program (small_molecule) at GALECTIN THERAPEUTICS INC with 2 ClinicalTrials.gov record(s).

Program details

Company
GALECTIN THERAPEUTICS INC
Indication
Colorectal Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials